Alotaibi, A. S., Yilmaz, M., Kanagal-Shamanna, R., Loghavi, S., Kadia, T. M., DiNardo, C. D., . . . Daver, N. (2020). Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors. Blood Cancer Discov.
Chicago ZitierstilAlotaibi, Ahmad S., et al. "Patterns of Resistance Differ in Patients With Acute Myeloid Leukemia Treated With Type I Versus Type II FLT3 Inhibitors." Blood Cancer Discov 2020.
MLA ZitierstilAlotaibi, Ahmad S., et al. "Patterns of Resistance Differ in Patients With Acute Myeloid Leukemia Treated With Type I Versus Type II FLT3 Inhibitors." Blood Cancer Discov 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.